<SEC-DOCUMENT>0001401914-22-000076-index.html : 20220809
<SEC-HEADER>0001401914-22-000076.hdr.sgml : 20220809
<ACCEPTANCE-DATETIME>20220809160745
ACCESSION NUMBER:		0001401914-22-000076
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20220809
DATE AS OF CHANGE:		20220809
EFFECTIVENESS DATE:		20220809

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Dare Bioscience, Inc.
		CENTRAL INDEX KEY:			0001401914
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				204139823
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-266699
		FILM NUMBER:		221148300

	BUSINESS ADDRESS:	
		STREET 1:		3655 NOBEL DRIVE
		STREET 2:		SUITE 260
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92122
		BUSINESS PHONE:		858-926-7655

	MAIL ADDRESS:	
		STREET 1:		3655 NOBEL DRIVE
		STREET 2:		SUITE 260
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92122

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cerulean Pharma Inc.
		DATE OF NAME CHANGE:	20090714

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Tempo Pharmaceuticals Inc
		DATE OF NAME CHANGE:	20070604
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>s-82022.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: s-82022.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>a1071s-8xfeetableexhibit1.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
Document 2 - file: a1071s-8xfeetableexhibit1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>a51opinion-sx8.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 3 - file: a51opinion-sx8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>a231mhmconsents-8.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 4 - file: a231mhmconsents-8.htm

</DOCUMENT>
</SEC-DOCUMENT>